Karyopharm Therapeutics (KPTI) Change in Inventory (2019 - 2025)
Karyopharm Therapeutics (KPTI) reported Change in Inventory of $72000.0 for Q4 2025, up 7.46% on a YoY basis from $67000.0 in Q4 2024, and up 107.02% quarter-over-quarter from -$1.0 million in Q3 2025.
Karyopharm Therapeutics (KPTI) Change in Inventory (2019 - 2025) Analysis & Trends
Karyopharm Therapeutics has reported Change in Inventory for 7 years, with the latest figure at $72000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 7.46% year-over-year to $72000.0; the trailing twelve-month figure through Dec 2025 stood at -$701000.0 (down 141.33% YoY), and the FY2025 full-year result was -$701000.0, down 141.33% from the prior year.
- Change in Inventory for Q4 2025 stood at $72000.0, up from -$1.0 million in the prior quarter.
- The five-year high for Change in Inventory was $1.2 million in Q3 2024, with the low at -$1.0 million in Q3 2025.
- Historically, Change in Inventory has averaged $69700.0 across 5 years, with a median of $2500.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Inventory jumped 743.8% — and 2025, when it sank 185.79%.
- Karyopharm Therapeutics' Change in Inventory stood at $77000.0 in 2021, then sank by 132.47% to -$25000.0 in 2022, then plunged by 148.0% to -$62000.0 in 2023, then surged by 208.06% to $67000.0 in 2024, then rose by 7.46% to $72000.0 in 2025.
- The last three Change in Inventory figures came in at $72000.0 (Q4 2025), -$1.0 million (Q3 2025), and $223000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Karyopharm Therapeutics | 95.31 Mn | 31.56 Mn | 32.74 Mn | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | -1.03 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 707,000.00 |
| Jun 30, 2024 | 707,000.00 |
| Mar 31, 2024 | -274,000.00 |
| Mar 31, 2024 | -274,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Sep 30, 2023 | -567,000.00 |
| Sep 30, 2023 | -567,000.00 |